Schedule 13G ownership disclosure
TENAX THERAPEUTICS, INC.
Security class unavailable · CUSIP: 88032L100
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 2,693,537
- Percent of class
- 9.5800%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-16-000095
- Form type
- SC 13G
- Filer
- SABBY MANAGEMENT, LLC
- CIK
- CIK 1535610
- Filed
- Jan 11, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership